Ozempic 3.0? This drug causes the greatest weight loss — by far
Researchers from Canada reviewed the results of 26 trials to determine which of the weight loss jabs are the most effective for obese adults who do not have diabetes.
The weight loss drug revolution is shrinking America's waistline
Losing weight in the new year won't take the same shape as it did in the past. Why it matters: The emergence of groundbreaking new weight-loss drugs is transforming how Americans shed pounds. Nearly 18 million Americans are expected to be taking versions of GLP-1 drugs by 2029,
America’s love-hate relationship with the new weight-loss drugs
Nearly half of US adults admit they’d take one of the newer, injectable weight loss drugs, but that number falls significantly when they learn that the weight might come back when the meds are stopped.
Retatrutide outperforms Ozempic in weight loss, new study finds
Experimental weight-loss drug Retatrutide shows promise, helping obese adults lose up to 22% of their weight in 48 weeks. Mimicking three hormones, it outperforms FDA-approved treatments like Ozempic and Wegovy.
As demand for weight-loss drugs rises, states grapple with Medicaid coverage
Over her three-decade career, weight management physician Dr. Sarah Ro has seen hundreds of patients. Many of them are on Medicaid and have become yo-yo dieters who, despite their best efforts at changing their eating habits and lifestyles,
How use of weight-loss drugs such as Ozempic has grown in Washington state
Axios Visuals The emergence of groundbreaking weight-loss drugs is transforming how Americans shed pounds, including in Washington state. The big picture: Nearly 18 million Americans are expected to be taking versions of GLP-1 drugs by 2029,
Health Matters: GLP-1 drugs work for weight loss, study finds
McGill University researchers say their study has found GLP-1 drugs are safe and effective for treating obesity and overweight adults without diabetes. The authors say the findings support using the medication to treat those who are overweight and obese among otherwise healthy patients.
FDA issues draft guidance on developing weight loss drugs
The U.S. FDA has released a new draft guidance for drugmakers to aid them in developing new treatments for obesity. The new document replaces an earlier draft guidance issued in February 2007. The new guidance stated that its focus is on the design of clinical trials and endpoints to demonstrate sustained weight loss,
Should Medicaid Pay for Ozempic and Other Weight-Loss Drugs?
With 13 states offering coverage, it’s already a $3.9 billion cost. Some state officials say reducing obesity will save programs money in the long run.
Professor Tim Spector issues weight loss jab food warning
Professor Tim Spector and his Zoe co-founder Jonathan Wolf have issued advice for those looking to change their diets in the ...
Life & Style Weekly4d
Celebrities Who Have Spoken Out About Ozempic: Who Has Discussed the Weight Loss Drug?
The weight loss medication ... to using the drug and described their results. The FDA-approved semaglutide works with the brain to reduce food cravings. The once-a-week injection makes a ...
‘An insatiable itch’: Why some people are turning to weight-loss medications to help quiet food noise
Savannah Mendoza used to spend most of her paychecks on food delivery apps and at fast food drive-thrus, trying to satisfy a ...
Psychology Today13d
The New Mindset for Medication-Assisted Weight Loss
Weight loss feels like a second job. Relies on "top-down," deliberate changes in lifestyle. Table 2. Medication-era mindset Don't enter the new GLP-1 medicine health and weight loss ...